Last Accessed News Today

<p>European Congress of Psychiatry 2024: New study reveals significant association between prenatal cannabis use disorder (CUD) and an increased risk of ADHD, autism, and intellectual disability in children.</p>

Shanghai Weixing Optical issued a significant payment to HOYA Vision Care to obtain a limited duration license to Defocus Incorporated

Building on expertise in RSV prevention, acquisition will accelerate ambition to deliver portfolio of protective interventions to address high unmet needs in infectious diseases ...

AstraZeneca to acquire US-based clinical-stage biopharmaceutical company, Icosavax

A4665w FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or...

AstraZeneca has entered into a definitive agreement to acquire Icosavax, Inc. (NASDAQ: ICVX), a US-based clinical-stage biopharmaceutical company focused on developing differentiated, high-potential vaccines using an innovative, protein virus-like particle (VLP) platform. The proposed acquisition will build on ...

A new GSK survey shows a large number of adults do not understand how shingles may be triggered1 More than half of adults surveyed incorrectly believe that you...

/PRNewswire/ -- Takeda (TSE:4502/NYSE:TAK) today announced the European Commission has approved TAKHZYRO® (lanadelumab) for the routine prevention of recurrent...

- TAKHZYRO® is the First Routine Prevention Treatment of HAE Approved in the EU for Patients Under the Age...

- TAKHZYRO® is the First Routine Prevention Treatment of HAE Approved in the EU for Patients Under the Age of Six.